Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Spontaneous
Cervical tissue changes in women with miscarriage: a morphological and biochemical investigation.
Abortion, Spontaneous
Detection of MMP-9 and TIMP-3 mRNA expression in the villi of patients undergoing early spontaneous abortion: A report of 30 cases.
Abortion, Spontaneous
Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies.
Abortion, Spontaneous
Effect of blockage of costimulatory signal on murine abortion-prone model.
Abortion, Spontaneous
Matrix metalloproteinases improves trophoblast invasion and pregnancy potential in mice.
Abortion, Spontaneous
Reduced expression of PD-L1 in autoimmune thyroiditis attenuate trophoblast invasion through ERK/MMP pathway.
Abortion, Spontaneous
Spontaneous abortion is preceded by an altered serum concentration of matrix metalloproteinases.
Abortion, Spontaneous
The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population.
Abscess
Histochemical localization of neutral proteases released during development of rat periradicular lesion.
Abscess
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Abscess
Involvement of the Commensal Organism Bacillus subtilis in the Pathogenesis of Anastomotic Leak.
Abscess
Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro.
Abscess
The zymographic evaluation of gelatinase (MMP-2 and -9) levels in acute and chronic periapical abscesses.
Acantholysis
Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease.
Acidosis
d-Lactic acid interferes with the effects of platelet activating factor on bovine neutrophils.
Acidosis, Respiratory
[Effects of acidification pretreatment for respiratory acidosis on the expression of matrix metalloproteinase-9 in rat lung tissues following ischemia/reperfusion].
Acne Vulgaris
Different cutaneous innate immunity profiles in acne patients with and without atrophic scars.
Acne Vulgaris
Induction of toll-like receptors by Propionibacterium acnes.
Acne Vulgaris
Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin.
Acquired Immunodeficiency Syndrome
HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway.
Acromegaly
Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.
Acute Coronary Syndrome
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
Acute Coronary Syndrome
Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.
Acute Coronary Syndrome
Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
Biomarkers of plaque instability in acute coronary syndrome patients.
Acute Coronary Syndrome
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Acute Coronary Syndrome
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Acute Coronary Syndrome
Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.
Acute Coronary Syndrome
EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
Acute Coronary Syndrome
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Acute Coronary Syndrome
Factors involved in sudden coagulation observed in patients with acute myocardial infarction.
Acute Coronary Syndrome
Factors which influence the levels of ST-2, Galectin-3 and MMP-9 in Acute Coronary Syndrome.
Acute Coronary Syndrome
Hyperbaric Oxygen Effect on MMP-9 After a Vascular Insult.
Acute Coronary Syndrome
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
Acute Coronary Syndrome
Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
Acute Coronary Syndrome
Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Acute Coronary Syndrome
Long Term Prognostic Utility of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome - A Systematic Review.
Acute Coronary Syndrome
Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome.
Acute Coronary Syndrome
Matrix Metalloproteinase-9 as a Marker for Plaque Rupture and a Predictor of Adverse Clinical Outcome in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Acute Coronary Syndrome
Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.
Acute Coronary Syndrome
Matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
Matrix metalloproteinase-9 index as a possible parameter for predicting acute coronary syndrome in diabetics.
Acute Coronary Syndrome
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells.
Acute Coronary Syndrome
Matrix metalloproteinases in coronary artery disease.
Acute Coronary Syndrome
Metalloproteinases in Diabetics and Nondiabetics during Acute Coronary Syndromes and after 3 Months.
Acute Coronary Syndrome
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
Acute Coronary Syndrome
Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Acute Coronary Syndrome
Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
Acute Coronary Syndrome
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Acute Coronary Syndrome
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Acute Coronary Syndrome
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Acute Coronary Syndrome
PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Acute Coronary Syndrome
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Acute Coronary Syndrome
Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
Acute Coronary Syndrome
Serum matrix metalloproteinase-9 levels in acute coronary syndrome patients with and without hyperglycemia.
Acute Coronary Syndrome
Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.
Acute Coronary Syndrome
T-cells in myocardial infarction: Culprit instigators or mere effectors?
Acute Coronary Syndrome
The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.
Acute Coronary Syndrome
The Role of FAK in the Secretion of MMP9 after CD147 Stimulation in Macrophages.
Acute Coronary Syndrome
The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome.
Acute Coronary Syndrome
Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
Acute Coronary Syndrome
Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
Acute Coronary Syndrome
[Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]
Acute Coronary Syndrome
[Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease]
Acute Coronary Syndrome
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
Acute Coronary Syndrome
[Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease].
Acute Coronary Syndrome
[Clinical significance of matrix metalloproteinase-9 and tissue factors secreted by cultured monocyte-derived macrophage of patients with coronary heart disease in vitro and the intervenient effect of puerarin on them]
Acute Coronary Syndrome
[Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome]
Acute Coronary Syndrome
[Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome]
Acute Coronary Syndrome
[Study of relations between matrix metalloproteinase-9 polymorphism (C-1562T) and acute coronary syndrome in Han population of China]
Acute Kidney Injury
Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Acute Kidney Injury
Matrix Metalloproteinase 9 and Vasodilator-Stimulated Phosphoprotein Related to Acute Kidney Injury in Severe Acute Pancreatitis Rats.
Acute Kidney Injury
Matrix metalloproteinase-9, 10, and stress hyperglycaemia in acute kidney injury.
Acute Kidney Injury
MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.
Acute Kidney Injury
Urinary biomarkers in the early diagnosis of acute kidney injury.
Acute Lung Injury
3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways.
Acute Lung Injury
A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model.
Acute Lung Injury
Acidic Preconditioning Protects Against Ischemia-Reperfusion Lung Injury Via Inhibiting the Expression of Matrix Metalloproteinase 9.
Acute Lung Injury
Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.
Acute Lung Injury
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Acute Lung Injury
Dexamethasone Ameliorates H2S-Induced Acute Lung Injury by Alleviating Matrix Metalloproteinase-2 and -9 Expression.
Acute Lung Injury
Doxycycline alleviates paraquat-induced acute lung injury by inhibiting neutrophil-derived matrix metalloproteinase 9.
Acute Lung Injury
Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury.
Acute Lung Injury
Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass.
Acute Lung Injury
Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury.
Acute Lung Injury
Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide.
Acute Lung Injury
Ginkgo biloba leaves extract (EGb 761) attenuates lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and NF-?B-dependent matrix metalloproteinase-9 pathway.
Acute Lung Injury
Hirsutanol A Attenuates Lipopolysaccharide-Mediated Matrix Metalloproteinase 9 Expression and Cytokines Production and Improves Endotoxemia-Induced Acute Sickness Behavior and Acute Lung Injury.
Acute Lung Injury
Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass.
Acute Lung Injury
Inhibition of matrix metalloproteinase-9 with low-dose doxycycline reduces acute lung injury induced by cardiopulmonary bypass.
Acute Lung Injury
Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-?B signaling pathway and MMP-9 expression.
Acute Lung Injury
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.
Acute Lung Injury
LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation.
Acute Lung Injury
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Acute Lung Injury
Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro.
Acute Lung Injury
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.
Acute Lung Injury
Neutrophil elastase ameliorates matrix metalloproteinase-9 to promote lipopolysaccharide-induced acute lung injury in mice 1.
Acute Lung Injury
Neutrophil proteinases in hydrochloric acid- and endotoxin-induced acute lung injury: evaluation of interstitial protease activity by in situ zymography.
Acute Lung Injury
Novel 5-Hydroxy, 5-Substituted Benzenesulfonamide Pyrimidine-2,4,6-Triones Attenuate Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of the Gelatinases, MMP-2 and MMP-9.
Acute Lung Injury
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Acute Lung Injury
Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation.
Acute Lung Injury
Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.
Acute Lung Injury
Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
Acute Lung Injury
The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.
Acute Lung Injury
Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents.
Acute Lung Injury
Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury.
Acute Lung Injury
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs.
Acute Lung Injury
[Effects of dexamethasone pretreatment on expression of matix metalloproteinase-9 in rats with acute lung injury induced by phosgene].
Acute Lung Injury
[Expression of various matrix metalloproteinases in mice with hyperoxia induced acute lung injury.]
Acute Lung Injury
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass.]
Acute-On-Chronic Liver Failure
Bioactivity of CD34+ cells in patients with acute-on-chronic liver failure.
Adenocarcinoma
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer.
Adenocarcinoma
Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.
Adenocarcinoma
alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.
Adenocarcinoma
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Adenocarcinoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenocarcinoma
Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Adenocarcinoma
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma
CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Adenocarcinoma
Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
Adenocarcinoma
Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Adenocarcinoma
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Adenocarcinoma
Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer.
Adenocarcinoma
Clinical significance of the content of biomolecular markers in invasive front of colon carcinomas.
Adenocarcinoma
Col IV and Fn distribution in prostatic adenocarcinoma and correlation of 67LR, MMP-9 and TIMP-1 expression with Gleason score.
Adenocarcinoma
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Adenocarcinoma
Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
Adenocarcinoma
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Adenocarcinoma
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Adenocarcinoma
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Adenocarcinoma
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Adenocarcinoma
Detection of serum MMPs in tumor-bearing hamsters.
Adenocarcinoma
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Adenocarcinoma
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
Adenocarcinoma
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer.
Adenocarcinoma
Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
Adenocarcinoma
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Adenocarcinoma
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Adenocarcinoma
Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
Adenocarcinoma
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Adenocarcinoma
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Adenocarcinoma
Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.
Adenocarcinoma
Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes.
Adenocarcinoma
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Adenocarcinoma
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Adenocarcinoma
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Adenocarcinoma
Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Adenocarcinoma
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Adenocarcinoma
Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination.
Adenocarcinoma
Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.
Adenocarcinoma
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Adenocarcinoma
High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma.
Adenocarcinoma
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Adenocarcinoma
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.
Adenocarcinoma
Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene.
Adenocarcinoma
Induction of matrix metalloproteinase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells.
Adenocarcinoma
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Adenocarcinoma
Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation.
Adenocarcinoma
Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.
Adenocarcinoma
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
Adenocarcinoma
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Adenocarcinoma
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
Adenocarcinoma
Matrix metalloproteinase-9 associated with heparan sulphate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells.
Adenocarcinoma
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.
Adenocarcinoma
Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Adenocarcinoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenocarcinoma
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Adenocarcinoma
Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma.
Adenocarcinoma
MMP-2 activation and stepwise progression of pulmonary adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin zymography.
Adenocarcinoma
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Adenocarcinoma
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Adenocarcinoma
Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung.
Adenocarcinoma
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Adenocarcinoma
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Adenocarcinoma
Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
Adenocarcinoma
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Adenocarcinoma
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Adenocarcinoma
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Adenocarcinoma
Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Adenocarcinoma
Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma
Adenocarcinoma
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
Adenocarcinoma
Salivary Proteome and Peptidome Profiling in Type 1 Diabetes Mellitus Using a Quantitative Approach.
Adenocarcinoma
Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Adenocarcinoma
Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo.
Adenocarcinoma
Systemic Ablation of MMP9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL-6 Expression in the Bone Marrow.
Adenocarcinoma
The ?-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor ?B signaling.
Adenocarcinoma
The assessment of matrix metalloproteinase-9 expression and angiogenesis in colorectal cancer.
Adenocarcinoma
The Cadin-2-en-1?-ol-1?-D-glucuronopyranoside Suppresses TPA-Mediated Matrix Metalloproteinase-9 Expression Through the ERK Signaling Pathway in MCF-7 Human Breast Adenocarcinoma Cells.
Adenocarcinoma
The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Adenocarcinoma
The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer.
Adenocarcinoma
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.
Adenocarcinoma
Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Adenocarcinoma
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.
Adenocarcinoma
[Effects of HSYA on expression of bFGF protein and MMP-9 in BGC-823 transplantation tumor of nude mice].
Adenocarcinoma
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Adenocarcinoma
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Adenocarcinoma
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]
Adenocarcinoma
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Adenocarcinoma
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Adenocarcinoma
[Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].
Adenocarcinoma
[The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]
Adenocarcinoma in Situ
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma of Lung
?-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Adenocarcinoma of Lung
AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9.
Adenocarcinoma of Lung
Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling.
Adenocarcinoma of Lung
Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
Adenocarcinoma of Lung
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma of Lung
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Adenocarcinoma of Lung
Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation.
Adenocarcinoma of Lung
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Adenocarcinoma of Lung
Curcumol inhibits lung adenocarcinoma growth and metastasis via inactivation of PI3K/AKT and Wnt/ß-catenin pathway.
Adenocarcinoma of Lung
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Adenocarcinoma of Lung
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Adenocarcinoma of Lung
Elevated Krüppel-like factor 5 expression in spatiotemporal mouse lungs is similar to human congenital cystic adenomatoid malformation of the lungs.
Adenocarcinoma of Lung
GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
Adenocarcinoma of Lung
Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Adenocarcinoma of Lung
Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.
Adenocarcinoma of Lung
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
Adenocarcinoma of Lung
Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Adenocarcinoma of Lung
Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation.
Adenocarcinoma of Lung
Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis.
Adenocarcinoma of Lung
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Adenocarcinoma of Lung
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-?B-mediated matrix metalloproteinase-9 expression.
Adenocarcinoma of Lung
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Adenocarcinoma of Lung
Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma.
Adenocarcinoma of Lung
Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway.
Adenocarcinoma of Lung
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression.
Adenocarcinoma of Lung
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Adenocarcinoma of Lung
Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Adenocarcinoma of Lung
Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.
Adenocarcinoma of Lung
Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-?B pathway in tumor-bearing nude mice.
Adenocarcinoma of Lung
[Anti-sense nucleic acid of CyclinD1 induces apoptosis of lung adenocarcinoma cancer cell A549.]
Adenocarcinoma of Lung
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma of Lung
[Construction of a CD147 lentiviral expression vector and establishment of its stably transfected A549 cell line].
Adenocarcinoma of Lung
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Adenocarcinoma of Lung
[Experimental study of targeting MMP-9 deoxyribozyme role of adhesion and migration in human lung adenocarcinoma cancer cell.]
Adenocarcinoma of Lung
[MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
Adenocarcinoma of Lung
[Propofol suppresses invasion of human lung cancer A549 cells by down-regulating aquaporin-3 and matrix metalloproteinase-9].
Adenocarcinoma, Bronchiolo-Alveolar
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma, Follicular
Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Adenocarcinoma, Follicular
[Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid.]
Adenocarcinoma, Mucinous
Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
Adenocarcinoma, Mucinous
Clinicopathological study of the colorectal mucinous carcinomas.
Adenoma
A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
Adenoma
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.
Adenoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenoma
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.
Adenoma
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Adenoma
Evaluation of matrix metalloproteinases (MMP)-2 and MMP-9 activity in serum and biochemical and hematological parameters in spontaneous canine cutaneous tumors before and after surgical treatment.
Adenoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Adenoma
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Adenoma
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Adenoma
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Adenoma
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Adenoma
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
Adenoma
Inhibition of pulmonary adenoma in diethylnitrosamine-induced rats by Rhizoma paridis saponins.
Adenoma
Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse.
Adenoma
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Adenoma
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
Adenoma
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenoma
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Adenoma
Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.
Adenoma
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Adenoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenoma
Measuring gelatinase activity in colorectal cancer.
Adenoma
Role of matrix metalloproteinase 9 in pituitary tumor behavior.
Adenoma
Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Adenoma
Role of matrix metalloproteinases in colorectal carcinogenesis.
Adenoma
Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Adenoma
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
Adenoma
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Adenoma
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Adenoma
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.
Adenoma
Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence.
Adenoma
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Adenoma
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Adenoma
[Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours]
Adenoma
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]
Adenoma, Liver Cell
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Adenoma, Oxyphilic
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors.
Adenoma, Oxyphilic
Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma.
Adenoma, Oxyphilic
Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma.
Adenoma, Pleomorphic
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Adenoma, Pleomorphic
Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
Adenoma, Pleomorphic
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
Adenoma, Pleomorphic
[The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]
Adenoma, Villous
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenomatous Polyposis Coli
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenomatous Polyposis Coli
Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.
Adenomatous Polyps
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Adenomatous Polyps
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Adenomatous Polyps
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Adenomyosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Adenomyosis
Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
Adenomyosis
Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis.
Adenomyosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Adenomyosis
Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis.
Adrenal Cortex Neoplasms
Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Aggressive Periodontitis
Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis.
Aggressive Periodontitis
Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients.
Aggressive Periodontitis
MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis.
Aggressive Periodontitis
Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients.
AIDS Dementia Complex
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
AIDS Dementia Complex
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
AIDS-Associated Nephropathy
Matrix metalloproteinase-9 expression in renal biopsies of patients with HIV-associated nephropathy.
Airway Obstruction
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Airway Obstruction
Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Airway Obstruction
Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Airway Obstruction
Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.
Airway Obstruction
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Airway Obstruction
[Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease]
Albuminuria
Absence of Gelatinase (MMP-9) or Collagenase (MMP-13) Attenuates Adriamycin-Induced Albuminuria and Glomerulosclerosis.
Albuminuria
Anti-Diabetic and Anti-Nephritic Activities of Grifola frondosa Mycelium Polysaccharides in Diet-Streptozotocin-Induced Diabetic Rats Via Modulation on Oxidative Stress.
Albuminuria
Canonical Wnt/?-catenin signaling mediates transforming growth factor-?1-driven podocyte injury and proteinuria.
Albuminuria
Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.
Albuminuria
Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
Albuminuria
Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.
Albuminuria
The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
Albuminuria
Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.
Alopecia
Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: consequences for the regulation of hair growth.
Alopecia Areata
Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
Alveolar Bone Loss
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs.
Alveolar Bone Loss
Effects of estrogen deficiency followed by streptozotocin-induced diabetes on periodontal tissues of female rats.
Alveolar Bone Loss
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
Alveolar Bone Loss
Exenatide and Sitagliptin Decrease Interleukin 1?, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis.
Alveolar Bone Loss
Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats.
Alveolar Bone Loss
Human ?-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.
Alveolar Bone Loss
Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat.
Alveolar Bone Loss
The Effects of a Novel Botanical Agent on LPS-Induced Alveolar Bone Loss in Rats.
Alveolitis, Extrinsic Allergic
Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
Alzheimer Disease
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Alzheimer Disease
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Alzheimer Disease
Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP.
Alzheimer Disease
Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.
Alzheimer Disease
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Alzheimer Disease
Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.
Alzheimer Disease
Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1.
Alzheimer Disease
Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease.
Alzheimer Disease
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Alzheimer Disease
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
Alzheimer Disease
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Alzheimer Disease
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.
Alzheimer Disease
Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease.
Alzheimer Disease
Involvement of matrix metalloproteinase-9 in amyloid-? 1-42-induced shedding of the pericyte proteoglycan NG2.
Alzheimer Disease
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Alzheimer Disease
Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease.
Alzheimer Disease
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.
Alzheimer Disease
Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics.
Alzheimer Disease
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.
Alzheimer Disease
Medroxyprogesterone Acetate Impairs Amyloid Beta Degradation in a Matrix Metalloproteinase-9 Dependent Manner.
Alzheimer Disease
Nitric oxide-mediated regulation of ?-amyloid clearance via alterations of MMP-9/TIMP-1.
Alzheimer Disease
Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease.
Alzheimer Disease
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Alzheimer Disease
Scavenging effect of Naoerkang on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer's disease.
Ameloblastoma
A novel ameloblastoma cell line (AM-3) secretes MMP-9 in response to Wnt-3a and induces osteoclastogenesis.
Ameloblastoma
Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids.
Ameloblastoma
Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/?-catenin signalling.
Ameloblastoma
Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.
Ameloblastoma
Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
Ameloblastoma
Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Ameloblastoma
Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
Ameloblastoma
Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases.
Ameloblastoma
Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis.
Ameloblastoma
Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.
Ameloblastoma
Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
Ameloblastoma
MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Ameloblastoma
Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures.
Ameloblastoma
The expression of NF-kappaB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC.
Ameloblastoma
The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma.
Ameloblastoma
TNF-?-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT.
Ameloblastoma
[Clinical and morphological features of ameloblastomas.]
Ameloblastoma
[Expression of nuclear factor-kappaB, Ki-67 and matrix metalloproteinase-9 in calcifying odontogenic cyst]
Ameloblastoma
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Amyloid Neuropathies, Familial
Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.
Amyloidosis
Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes.
Amyloidosis
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Amyotrophic Lateral Sclerosis
Association studies of mmp-9 in Parkinson's disease and amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Amyotrophic Lateral Sclerosis
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
The C(-1562)T polymorphism of the MMP-9 gene and the risk of sporadic amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
[Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients]
Anaphylaxis
Markers Involved in Innate Immunity and Neutrophil Activation are Elevated during Acute Human Anaphylaxis: Validation of a Microarray Study.
Anaplasia
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Anemia
Modulation of the HGF/c-Met axis impacts prolonged hematopoietic progenitor mobilization following trauma and chronic stress.
Aneurysm
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Aneurysm
A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity.
Aneurysm
A novel murine elastase saccular aneurysm model for studying bone marrow progenitor-derived cell-mediated processes in aneurysm formation.
Aneurysm
A potential role for glycated cross-links in abdominal aortic aneurysm disease.
Aneurysm
An uncommon case of arterial aneurysms association with high plasma levels of Matrix Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin.
Aneurysm
Aneurysm Organization Effects of Gellan Sulfate Core Platinum Coil with Tenascin-C in a Simulated Clinical Setting and the Possible Mechanism.
Aneurysm
Arterial wall degeneration plus hemodynamic insult cause arterial wall remodeling and nascent aneurysm formation at specific sites in dogs.
Aneurysm
Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5?32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.
Aneurysm
Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Aneurysm
Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Aneurysm
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Aneurysm
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aneurysm
Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.
Aneurysm
Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.
Aneurysm
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
Aneurysm
Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.
Aneurysm
Comments regarding 'Plasma levels of matrix metalloproteinase-9: a possible diagnostic marker of successful endovascular aneurysm repair'.
Aneurysm
Comparative study of abdominal and thoracic aortic aneurysms: their pathogenesis and a gingival fibroblasts-based ex vivo treatment.
Aneurysm
Controlled release of osteopontin and interleukin-10 from modified endovascular coil promote cerebral aneurysm healing.
Aneurysm
Cysteine protease activity in the wall of abdominal aortic aneurysms.
Aneurysm
Differences in Elastin and Elastolytic Enzymes between Men and Women with Abdominal Aortic Aneurysm.
Aneurysm
Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed.
Aneurysm
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.
Aneurysm
Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Aneurysm
Early Increased MT1-MMP Expression and Late MMP-2 and MMP-9 Activity during Angiotensin II Induced Aneurysm Formation.
Aneurysm
Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Aneurysm
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
Aneurysm
Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
Aneurysm
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Aneurysm
Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats.
Aneurysm
Expression of Matrix Metalloproteinases and Endogenous Inhibitors in Abdominal Aortic Aneurysm and Aortoiliac Occlusive Disease (Syndrome Leriche).
Aneurysm
Expression of MMP-2, MMP-9, and NGAL in Tissue and Serum of Patients with Vascular Aneurysms and Their Modulation by Statin Treatment: A Pilot Study.
Aneurysm
Free radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Aneurysm
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Aneurysm
Gender differences in experimental aortic aneurysm formation.
Aneurysm
Genes predisposing to rapid aneurysm growth.
Aneurysm
Hemodynamics and pathology of an enlarging abdominal aortic aneurysm model in rabbits.
Aneurysm
Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms.
Aneurysm
Homocysteine and metalloprotease-3 and -9 in patients with ascending Aorta Aneurysms.
Aneurysm
Hyperbaric Oxygen Effect on MMP-9 After a Vascular Insult.
Aneurysm
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Aneurysm
Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms.
Aneurysm
In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta.
Aneurysm
Increased Plasma Levels of Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin in a Rare Case of Multiple Artery Aneurysm.
Aneurysm
Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms.
Aneurysm
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aneurysm
Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.
Aneurysm
Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat.
Aneurysm
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.
Aneurysm
Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.
Aneurysm
Interleukin-12 and -23 blockade mitigates elastase-induced abdominal aortic aneurysm.
Aneurysm
Levels of MMP-9 in patients with intracranial aneurysm: Relation with risk factors, size and clinical presentation.
Aneurysm
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Aneurysm
Magnetic resonance imaging assessment of proteolytic enzyme concentrations and biologic properties of intraluminal thrombus in abdominal aortic aneurysms.
Aneurysm
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aneurysm
Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
Aneurysm
Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in caucasians with intracranial aneurysms.
Aneurysm
Matrix metalloproteinase-9 in cerebral aneurysms.
Aneurysm
Matrix metalloproteinase-9 may play a role in recanalization and recurrence after therapeutic embolization of aneurysms or arteries.
Aneurysm
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Aneurysm
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
Aneurysm
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Aneurysm
Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm.
Aneurysm
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms.
Aneurysm
MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Aneurysm
MMP-9: biomarker for abdominal aneurysm.
Aneurysm
MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans.
Aneurysm
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.
Aneurysm
Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition.
Aneurysm
Osteoclast-Like Cells in Aneurysmal Disease Exhibit an Enhanced Proteolytic Phenotype.
Aneurysm
Persistence of Intraluminal Thrombus Makes Saccular Aneurysm More Biologically Active than Fusiform in an Experimental Rat Model.
Aneurysm
Plasma levels of matrix metalloproteinase-9: a possible diagnostic marker of successful endovascular aneurysm repair.
Aneurysm
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
Aneurysm
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
Aneurysm
Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases.
Aneurysm
Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms.
Aneurysm
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.
Aneurysm
Rapamycin suppresses experimental aortic aneurysm growth.
Aneurysm
Re: Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Aneurysm
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
Aneurysm
RETINAL CAPILLARY MACROANEURYSMS.
Aneurysm
Role of matrix metalloproteinases in abdominal aortic aneurysms.
Aneurysm
Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms.
Aneurysm
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
Aneurysm
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Aneurysm
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Aneurysm
Simvastatin suppresses experimental aortic aneurysm expansion.
Aneurysm
Size matters: the relationship between MMP-9 expression and aortic diameter.
Aneurysm
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm.
Aneurysm
Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
Aneurysm
Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Aneurysm
Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.
Aneurysm
The Elevated Level of Circulating Matrix Metalloproteinase-9 in Patients with Abdominal Aortic Aneurysms Decreased to Levels Equal to Those of Healthy Controls after an Aortic Repair.
Aneurysm
The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair.
Aneurysm
The potential role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in the development of abdominal aortic aneurysms.
Aneurysm
The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms.
Aneurysm
Time-dependent and site-dependent morphological changes in rupture-prone arteries: ovariectomized rat intracranial aneurysm model.
Aneurysm
Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis.
Aneurysm
Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Aneurysm
Vascular extracellular matrix remodeling in cerebral aneurysms.
Aneurysm
Vascular Remodeling and Immune Cell Infiltration in Splenic Artery Aneurysms.
Aneurysm
[Expression of matrix metalloproteinase-9 in the arachnoid membrane around posterior communicating artery aneurysms].
Aneurysm
[In situ localization of mRNA gelatinases in cerebral aneurysms]
Aneurysm
[The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats]
Aneurysm, Dissecting
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection.
Aneurysm, Dissecting
Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population.
Aneurysm, Dissecting
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aneurysm, Dissecting
Insulin-like growth factor-binding protein 3 inhibits angiotensin II-induced aortic smooth muscle cell phenotypic switch and matrix metalloproteinase expression.
Aneurysm, Dissecting
Mechanical Strain Induced Expression of Matrix Metalloproteinase-9 via Stretch-Activated Channels in Rat Abdominal Aortic Dissection.
Aneurysm, Dissecting
Mechanical stretch aggravates aortic dissection by regulating MAPK pathway and the expression of MMP-9 and inflammation factors.
Aneurysm, Dissecting
Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection.
Aneurysm, Dissecting
Overexpression of interleukin-1? and interferon-? in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells.
Aneurysm, Dissecting
Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.
Aneurysm, Dissecting
Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-? and matrix metalloproteinase-9 in aortic dissection.
Aneurysm, Dissecting
Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection.
Aneurysm, Dissecting
Serum levels of matrix metalloproteinase 9 and toll-like receptor 4 in acute aortic dissection: a case-control study.
Aneurysm, Dissecting
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Aneurysm, Dissecting
Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta.
Aneurysm, Dissecting
The analysis of the levels of plasma inflammation-related cytokines and endotoxins in patients with acute aortic dissection.
Aneurysm, Dissecting
Transforming growth factor-?1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-?B pathways.
Aneurysm, Dissecting
[Effect of bilateral superior cervical sympathetic ganglion occlusion on pathological process of aortic dissection and its mechanism].
Aneurysm, Dissecting
[MMP-9 gene -1562C/T polymorphism in aortic dissection in Chinese hypertensive patients]
Aneurysm, Ruptured
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Aneurysm, Ruptured
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms.
Angina Pectoris
Association of serum MMP-9 with autoantibodies against oxidized LDL.
Angina Pectoris
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina Pectoris
Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Angina, Stable
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
Angina, Stable
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture.
Angina, Stable
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Angina, Stable
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina, Stable
EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
Angina, Stable
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Angina, Stable
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.
Angina, Stable
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Angina, Stable
Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
Angina, Stable
Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina.
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Angina, Stable
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
Angina, Stable
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Angina, Stable
Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
Angina, Stable
Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study.
Angina, Stable
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
Angina, Stable
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Angina, Unstable
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Angina, Unstable
Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
Angina, Unstable
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina, Unstable
Curcumin effects on myeloperoxidase, interleukin-18 and matrix metalloproteinase-9 inflammatory biomarkers in patients with unstable angina: A randomized clinical trial.
Angina, Unstable
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Angina, Unstable
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Angina, Unstable
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
Angina, Unstable
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Angina, Unstable
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
Angina, Unstable
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10.
Angina, Unstable
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.
Angina, Unstable
Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina.
Angina, Unstable
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Angina, Unstable
Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
Angina, Unstable
Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
Angina, Unstable
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects.
Angina, Unstable
[Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]
Angiofibroma
Metalloproteinases in juvenile angiofibroma--a collagen rich tumor.
Angiofibroma
Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis.
Anodontia
Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia.
Anovulation
Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome.
Aortic Aneurysm
Amelioration of salvianolic acid C on aortic structure in apolipoprotein E-deficient mice treated with angiotension II.
Aortic Aneurysm
Chymase as a novel target for the prevention of vascular diseases.
Aortic Aneurysm
Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: from the Dallas Heart Study.
Aortic Aneurysm
Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Aortic Aneurysm
Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.
Aortic Aneurysm
Effect of miR-21 on rat thoracic aortic aneurysm model by regulating the expressions of MMP-2 and MMP-9.
Aortic Aneurysm
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Aortic Aneurysm
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aortic Aneurysm
Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.
Aortic Aneurysm
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Aortic Aneurysm
MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats.
Aortic Aneurysm
Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.
Aortic Aneurysm
Plasma Matrix Metalloproteinase 9 Levels May Predict Endoleaks After Endovascular Aortic Aneurysm Repair.
Aortic Aneurysm
Role of PAR1-Egr1 in the Initiation of Thoracic Aortic Aneurysm in Fbln4-Deficient Mice.
Aortic Aneurysm
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
Aortic Aneurysm
Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study.
Aortic Aneurysm
SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration.
Aortic Aneurysm
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.
Aortic Aneurysm
The association between plasma matrix metalloproteinase-9 concentration and endoleak after endovascular aortic aneurysm repair: a meta-analysis.
Aortic Aneurysm
Transforming growth factor-?1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-?B pathways.
Aortic Aneurysm, Abdominal
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
Aortic Aneurysm, Abdominal
A Randomised Placebo-controlled Double-blind Trial to Evaluate Lipid-lowering Pharmacotherapy on Proteolysis and Inflammation in Abdominal Aortic Aneurysms.
Aortic Aneurysm, Abdominal
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
Aortic Aneurysm, Abdominal
Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5?32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.
Aortic Aneurysm, Abdominal
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aortic Aneurysm, Abdominal
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.
Aortic Aneurysm, Abdominal
Chymase as a novel target for the prevention of vascular diseases.
Aortic Aneurysm, Abdominal
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Aortic Aneurysm, Abdominal
Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis.
Aortic Aneurysm, Abdominal
Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
Aortic Aneurysm, Abdominal
Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants.
Aortic Aneurysm, Abdominal
Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
Aortic Aneurysm, Abdominal
Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Aortic Aneurysm, Abdominal
Early growth response factor-1 DNA enzyme 1 inhibits the formation of abdominal aortic aneurysm in rats.
Aortic Aneurysm, Abdominal
Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.
Aortic Aneurysm, Abdominal
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Aortic Aneurysm, Abdominal
Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
Aortic Aneurysm, Abdominal
Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA).
Aortic Aneurysm, Abdominal
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
EVAR and OPEN treatment of abdominal aortic aneurysm: What is the role of MMP-9 in the follow-up?
Aortic Aneurysm, Abdominal
Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma.
Aortic Aneurysm, Abdominal
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Genes predisposing to rapid aneurysm growth.
Aortic Aneurysm, Abdominal
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion.
Aortic Aneurysm, Abdominal
HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.
Aortic Aneurysm, Abdominal
Human Vascular Wall Mesenchymal Stromal Cells Contribute to Abdominal Aortic Aneurysm Pathogenesis Through an Impaired Immunomodulatory Activity and Increased Levels of Matrix Metalloproteinase-9.
Aortic Aneurysm, Abdominal
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Aortic Aneurysm, Abdominal
Increased Plasma Levels of Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin in a Rare Case of Multiple Artery Aneurysm.
Aortic Aneurysm, Abdominal
Loss of MURC/Cavin-4 induces JNK and MMP-9 activity enhancement in vascular smooth muscle cells and exacerbates abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Matrix metalloproteinase 9 activity in patients before and after endovascular or surgical repair of abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Matrix Metalloproteinase-9 Genotype as a Potential Genetic Marker for Abdominal Aortic Aneurysm.
Aortic Aneurysm, Abdominal
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
MF-tricyclic inhibits growth of experimental abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers.
Aortic Aneurysm, Abdominal
MMP-9: biomarker for abdominal aneurysm.
Aortic Aneurysm, Abdominal
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.
Aortic Aneurysm, Abdominal
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
Aortic Aneurysm, Abdominal
New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage.
Aortic Aneurysm, Abdominal
Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Aortic Aneurysm, Abdominal
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Aortic Aneurysm, Abdominal
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
Aortic Aneurysm, Abdominal
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Aortic Aneurysm, Abdominal
Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice.
Aortic Aneurysm, Abdominal
Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Aortic Aneurysm, Abdominal
Size matters: the relationship between MMP-9 expression and aortic diameter.
Aortic Aneurysm, Abdominal
Spatial differences of matrix metalloproteinase-2 and matrix metalloproteinase-9 within abdominal aortic aneurysm wall and intraluminal thrombus.
Aortic Aneurysm, Abdominal
Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Aortic Aneurysm, Abdominal
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm.
Aortic Aneurysm, Abdominal
The Elevated Level of Circulating Matrix Metalloproteinase-9 in Patients with Abdominal Aortic Aneurysms Decreased to Levels Equal to Those of Healthy Controls after an Aortic Repair.
Aortic Aneurysm, Abdominal
The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair.
Aortic Aneurysm, Abdominal
The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants.
Aortic Aneurysm, Abdominal
The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study.
Aortic Aneurysm, Abdominal
[Metalloproteases, vascular remodeling and atherothrombotic syndromes]
Aortic Aneurysm, Thoracic
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Aortic Aneurysm, Thoracic
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection.
Aortic Aneurysm, Thoracic
Changes in expressions of miR-22-3p and MMP-9 in rats with thoracic aortic aneurysm and their significance.
Aortic Aneurysm, Thoracic
Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
Aortic Aneurysm, Thoracic
Effect of miR-21 on rat thoracic aortic aneurysm model by regulating the expressions of MMP-2 and MMP-9.
Aortic Aneurysm, Thoracic
Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model.
Aortic Aneurysm, Thoracic
Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aortic Aneurysm, Thoracic
Overexpression of interleukin-1? and interferon-? in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells.
Aortic Aneurysm, Thoracic
Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study.
Aortic Aneurysm, Thoracic
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm.
Aortic Aneurysm, Thoracic
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation.
Aortic Diseases
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
Aortic Rupture
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Aortic Valve Stenosis
Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition.
Aortic Valve Stenosis
Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
Aortic Valve Stenosis
Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Aortic Valve Stenosis
Impact of several proinflammatory and cell degradation factors in patients with aortic valve stenosis.
Appendicitis
A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.
Appendicitis
Biomarkers to estimate the probability of complicated appendicitis.
Appendicitis
Local and systemic expressions of MMP-9, TIMP-1 and PAI-1 in patients undergoing surgery for clinically suspected appendicitis.
Appendicitis
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Arrhythmias, Cardiac
Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.
Arrhythmias, Cardiac
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.
Arteriosclerosis
4-O-Carboxymethylascochlorin Inhibits Expression Levels of on Inflammation-Related Cytokines and Matrix Metalloproteinase-9 Through NF-?B/MAPK/TLR4 Signaling Pathway in LPS-Activated RAW264.7 Cells.
Arteriosclerosis Obliterans
Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Arteriovenous Fistula
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.
Arteriovenous Fistula
Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation.
Arteriovenous Fistula
Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.
Arteriovenous Fistula
Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure.
Arteriovenous Fistula
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.
Arteriovenous Malformations
Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.
Arteriovenous Malformations
Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
Arteriovenous Malformations
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.
Arteriovenous Malformations
Increased expression of angiogenic factors in cultured human brain arteriovenous malformation endothelial cells.
Arteriovenous Malformations
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.
Arteriovenous Malformations
Suppression of MMP-9 by doxycycline in brain arteriovenous malformations.
Arteriovenous Malformations
The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations.
Arteritis
Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
Arteritis
Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis.
Arteritis
Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.
Arteritis
Inhibition of transforming growth factor ? worsens elastin degradation in a murine model of Kawasaki disease.
Arteritis
Matrix metalloproteinase-9 is elevated in serum of alcohol abusers.
Arteritis
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Arthralgia
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Arthritis
A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Arthritis
Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13).
Arthritis
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Arthritis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Arthritis
Cathepsin B and cystatin C play an inflammatory role in gouty arthritis of the knee.
Arthritis
Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac.
Arthritis
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis.
Arthritis
Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.
Arthritis
Chemokines and proteinases in autoimmune diseases and cancer.
Arthritis
Clinical significance of gelatinases in septic arthritis of native and replaced knees.
Arthritis
Collagen type III content of the long head of the biceps tendon as an indicator of glenohumeral arthritis.
Arthritis
Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9.
Arthritis
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
Arthritis
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Arthritis
Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.
Arthritis
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Arthritis
Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
Arthritis
Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Arthritis
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis
Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Arthritis
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Arthritis
Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.
Arthritis
Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Arthritis
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis
Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Arthritis
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis
Matrix metalloproteinases: role in arthritis.
Arthritis
Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Arthritis
MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody.
Arthritis
Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
Arthritis
Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist.
Arthritis
Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.
Arthritis
Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.
Arthritis
Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
Arthritis
Serum Levels of MDC and MMP-9 and the Relationship Between Serum Levels and Disease Activity in the Patients with Systemic Lupus Erythematosus.
Arthritis
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Arthritis
Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.
Arthritis
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
Arthritis
The significance of altered gelatinase expression in the synovium of patient with arthritic effusions.
Arthritis
Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1.
Arthritis
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis
[Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus]
Arthritis, Experimental
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.
Arthritis, Experimental
Blocking Matrix Metalloproteinase-9 Abrogates Collagen-Induced Arthritis via Inhibiting Dendritic Cell Migration.
Arthritis, Experimental
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis.
Arthritis, Experimental
Effective treatment of polydatin weakens the symptoms of collagen-induced arthritis in mice through its anti-oxidative and anti-inflammatory effects and the activation of MMP-9.
Arthritis, Experimental
Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Arthritis, Experimental
Localization and characterization of matrix metalloproteinase-9 in experimental rat adjuvant arthritis.
Arthritis, Experimental
Therapeutic effects of the total lignans from Vitex negundo seeds on collagen-induced arthritis in rats.
Arthritis, Experimental
Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis.
Arthritis, Experimental
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis, Experimental
[The effect of prolactin on the expression of matrix metalloproteinase-9 in the synovium of adjuvant arthritis rats].
Arthritis, Gouty
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Arthritis, Gouty
The clinical significance of gelatinase B in gouty arthritis of the knee.
Arthritis, Gouty
Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Arthritis, Infectious
Clinical significance of gelatinases in septic arthritis of native and replaced knees.
Arthritis, Infectious
Comparison of several biomarkers (MMP-2, MMP-9, the MMP-9 inhibitor TIMP-1, CTX-II, calprotectin, and COMP) in the synovial fluid and serum of patients with and without septic arthritis.
Arthritis, Infectious
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis, Infectious
Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids.
Arthritis, Infectious
Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis.
Arthritis, Juvenile
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Arthritis, Juvenile
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis, Juvenile
[Indices of matrix metalloproteinases (MMP-2, MMP-9, TIMP-1) with juvenile arthritis in children].
Arthritis, Psoriatic
Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.
Arthritis, Psoriatic
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Arthritis, Rheumatoid
A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis.
Arthritis, Rheumatoid
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Arthritis, Rheumatoid
A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin.
Arthritis, Rheumatoid
A study of metalloproteinases in fifty joint fluid specimens.
Arthritis, Rheumatoid
Association of tumor necrosis factor-? (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
Arthritis, Rheumatoid
Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.
Arthritis, Rheumatoid
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Arthritis, Rheumatoid
Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Arthritis, Rheumatoid
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Arthritis, Rheumatoid
Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.
Arthritis, Rheumatoid
Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.
Arthritis, Rheumatoid
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Arthritis, Rheumatoid
Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Arthritis, Rheumatoid
Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5.
Arthritis, Rheumatoid
Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
Arthritis, Rheumatoid
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
Arthritis, Rheumatoid
Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Arthritis, Rheumatoid
Expression Analysis of Matrix Metalloproteinase-9 Gene in Rheumatoid Arthritis Patients on Disease Modifying Anti-Rheumatic Drugs.
Arthritis, Rheumatoid
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Arthritis, Rheumatoid
Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis.
Arthritis, Rheumatoid
Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Arthritis, Rheumatoid
Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Human gelatinase B, a marker enzyme in rheumatoid arthritis, is inhibited by D-penicillamine: anti-rheumatic activity by protease inhibition.
Arthritis, Rheumatoid
Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.
Arthritis, Rheumatoid
Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.
Arthritis, Rheumatoid
Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.
Arthritis, Rheumatoid
LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
Arthritis, Rheumatoid
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Arthritis, Rheumatoid
Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.
Arthritis, Rheumatoid
Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-9 and autoimmune diseases.
Arthritis, Rheumatoid
Matrix Metalloproteinase-9 Production by Immortalized Human Chondrocyte Lines.
Arthritis, Rheumatoid
Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Arthritis, Rheumatoid
Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
Arthritis, Rheumatoid
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Arthritis, Rheumatoid
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Arthritis, Rheumatoid
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.
Arthritis, Rheumatoid
Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
Arthritis, Rheumatoid
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Arthritis, Rheumatoid
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.
Arthritis, Rheumatoid
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Arthritis, Rheumatoid
Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Tear film MMP accumulation and corneal disease.
Arthritis, Rheumatoid
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
Arthritis, Rheumatoid
[Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis]
Arthritis, Rheumatoid
[Effect of lipopolysaccharide on expression of matrix metalloproteinase-9 in human synoviocyte from patients with rheumatoid arthritis]
Arthritis, Rheumatoid
[The effect of prolactin on the expression of matrix metalloproteinase-9 in the synovium of adjuvant arthritis rats].
Arthritis, Rheumatoid
[The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance]
Arthritis, Rheumatoid
[Usefulness of examinations of serum levels of matrix metalloproteinases 1, MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1, hyaluronic acid and antibodies against cyclic citrullinated peptide in Lyme arthritis, rheumatoid arthritis and patients with arthritic complaints].
Asbestosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Asbestosis
SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain.
Ascorbic Acid Deficiency
Possible interplay between vitamin C deficiency and prolactin in pregnant women with premature rupture of membranes: facts and hypothesis.
Aspergillosis, Allergic Bronchopulmonary
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis.
Asthma
A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion.
Asthma
A functional polymorphism in MMP-9 is associated with childhood atopic asthma.
Asthma
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Asthma
A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.
Asthma
A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice.
Asthma
A water extract of Samchulkunbi-tang attenuates airway inflammation by inhibiting inos and MMP-9 activities in an ovalbumin-induced murine asthma model.
Asthma
Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.
Asthma
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.
Asthma
An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma.
Asthma
Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis.
Asthma
Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis.
Asthma
Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma.
Asthma
Balance between MMP-9 and TIMP-1 expressed by human bronchial epithelial cells: relevance to asthma.
Asthma
Bronchial dilatation in asthma: relation to clinical and sputum indices.
Asthma
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation.
Asthma
Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
Asthma
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Asthma
CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma.
Asthma
Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.
Asthma
DNA sequence variations of metalloproteinases: their role in asthma and COPD.
Asthma
Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.
Asthma
Effect of montelukast on markers of airway remodeling in children with asthma.
Asthma
Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Asthma
Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Asthma
Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma.
Asthma
Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts.
Asthma
Evaluation of inflammatory markers interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP-9) in asthma.
Asthma
Exhaled breath condensate MMP-9 level and its relationship w?th asthma severity and interleukin-4/10 levels in children.
Asthma
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
Asthma
Expression of matrix metalloproteinases MMP-9 within the airways in asthma.
Asthma
Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients.
Asthma
Functional polymorphism in the gelatinase B gene and asthma.
Asthma
German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells.
Asthma
HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2.
Asthma
Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma.
Asthma
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma.
Asthma
Increase in the Mediators of Asthma in Obesity and Obesity with Type 2 Diabetes: Reduction with Weight Loss.
Asthma
Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma.
Asthma
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma.
Asthma
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.
Asthma
Increased matrix metalloproteinase-9 in the airway after allergen challenge.
Asthma
Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma.
Asthma
Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma.
Asthma
Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV1 at 5-Year Follow-up.
Asthma
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics.
Asthma
Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients.
Asthma
Influence of rutin on the effects of neonatal cigarette smoke exposure-induced exacerbated MMP-9 expression, Th17 cytokines and NF-?B/iNOS-mediated inflammatory responses in asthmatic mice model.
Asthma
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.
Asthma
Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study.
Asthma
Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.
Asthma
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma.
Asthma
Levels of matrix metalloproteinase-9 and its inhibitor in bronchoalveolar lavage cells of asthmatic children.
Asthma
Levels of matrix metalloproteinase-9 and its inhibitor in guinea pig asthma model following ovalbumin challenge.
Asthma
Localization of Matrix Metalloproteinase (MMP)-9 in Lung Tissue of a Murine Model of Allergic Asthma.
Asthma
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
Asthma
Matrix metalloproteinase 9 is involved in airway inflammation in cough variant asthma.
Asthma
Matrix metalloproteinase-9 and airway remodeling in asthma.
Asthma
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.
Asthma
Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.
Asthma
Matrix metalloproteinase-9 in lung remodeling.
Asthma
Matrix metalloproteinase-9 in peripheral blood eosinophils.
Asthma
Matrix metalloproteinase-9 release from human leukocytes.
Asthma
Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.
Asthma
Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma.
Asthma
Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma.
Asthma
MFG-E8/integrin ?3 signaling contributes to airway inflammation response and airway remodeling in an ovalbumin-induced murine model of asthma.
Asthma
MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7.
Asthma
MMP-9 Cleaves SP-D and Abrogates Its Innate Immune Functions In Vitro.
Asthma
MMP-9 gene variants increase the risk for non-atopic asthma in children.
Asthma
Nasal lavage VEGF and TNF-? levels during a natural cold predict asthma exacerbations.
Asthma
Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids.
Asthma
Neutrophils from allergic asthmatic patients produce and release metalloproteinase-9 upon direct exposure to allergens.
Asthma
Non-invasive markers of airway inflammation and remodeling in childhood asthma.
Asthma
p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils.
Asthma
Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Asthma
Plasminogen activator inhibitor-1 in the pathogenesis of asthma.
Asthma
PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells.
Asthma
Polymorphic Variants 279R and 668Q Augment Activity of Matrix Metalloproteinase-9 in Breath Condensates of Children with Asthma.
Asthma
Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients.
Asthma
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma.
Asthma
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.
Asthma
Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: Modulation by immunostimulatory DNA.
Asthma
Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.
Asthma
Role of matrix metalloproteinases in asthma.
Asthma
Role of metalloproteinases MMP-2 in asthma.
Asthma
Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma.
Asthma
Serum MMP-9 is elevated in children with asthma.
Asthma
Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
Asthma
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
Asthma
Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair.
Asthma
Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Asthma
Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma.
Asthma
The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma.
Asthma
The role of inducible costimulatory molecular ligand (ICOSL) in children with neutrophilic asthma.
Asthma
The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway.
Asthma
The Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.
Asthma
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.
Asthma
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.
Asthma
[Effect of triggering receptor expressed on myeloid cells 2 overexpression on airway inflammation and remodeling in mice with allergic asthma].
Asthma
[Effects of all-trans retinoic acid on airway responsiveness and airway remodeling in rats with asthma].
Asthma
[Effects of Fritillariae Cirrhosae Bulbus on MMP-2,MMP-9 and TIMP-1 in murine asthma model].
Asthma
[MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma]
Asthma
[Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats]
Asthma
[The effect of melatonin on the regulation of collagen accumulation and matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA and protein in a murine model of chronic asthma]
Asthma, Aspirin-Induced
Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis.
Asthma, Occupational
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Asthma, Occupational
Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge.
Astrocytoma
Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
Astrocytoma
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.
Astrocytoma
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification.
Astrocytoma
Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
Astrocytoma
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Astrocytoma
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Astrocytoma
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Astrocytoma
Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Astrocytoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Astrocytoma
Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors.
Astrocytoma
Expression of timp-1, timp-2, 72-kda and 92-kda type-iv collagenase transcripts in human astrocytoma cell-lines - correlation with astrocytoma cell invasiveness.
Astrocytoma
Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes.
Astrocytoma
Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells.
Astrocytoma
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Astrocytoma
Inhibition of matrix metalloproteinase-9 gene expression by an isoflavone metabolite, irisolidone in U87MG human astroglioma cells.
Astrocytoma
Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1.
Astrocytoma
l-Glutamate in Middlebrook 7H9 culture medium upregulates matrix metalloproteinase-2 secretion from human astrocytoma cells.
Astrocytoma
Loss of Inhibitor of Growth (ING-4) Is Implicated in the Pathogenesis and Progression of Human Astrocytomas.
Astrocytoma
Matrix Metalloproteinase-9 Expression is Increased in Astrocytic Glioma and Associated with Prognosis of Patients.
Astrocytoma
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Astrocytoma
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Astrocytoma
Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide.
Astrocytoma
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Astrocytoma
Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase.
Astrocytoma
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Astrocytoma
Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways.
Astrocytoma
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Astrocytoma
The Effect of Sialic Acid on the Expression of miR-218, NF-kB, MMP-9, and TIMP-1.
Astrocytoma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Astrocytoma
TRAIL induces MMP-9 expression via ERK activation in human astrocytoma cells.
Astrocytoma
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.
Astrocytoma
Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry.
Ataxia Telangiectasia
Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.
Ataxia Telangiectasia
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Atherosclerosis
18F-FDG PET/MR-imaging in a Göttingen Minipig model of atherosclerosis: Correlations with histology and quantitative gene expression.
Atherosclerosis
4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK.
Atherosclerosis
7?-Hydroxycholesterol induces inflammation by enhancing production of chemokine (C-C motif) ligand 2.
Atherosclerosis
A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?
Atherosclerosis
Accurate targeting of activated macrophages based on synergistic activation of functional molecules uptake by scavenger receptor and matrix metalloproteinase.
Atherosclerosis
Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.
Atherosclerosis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Atherosclerosis
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Atherosclerosis
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon ?.
Atherosclerosis
Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
Atherosclerosis
Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the chinese han population: a case-control study.
Atherosclerosis
Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.
Atherosclerosis
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Atherosclerosis
Beta-adrenoceptor Activation by Norepinephrine Enhances Lipopolysaccharide-induced Matrix Metalloproteinase-9 Expression Through the ERK/JNK-c-Fos Pathway in Human THP-1 Cells.
Atherosclerosis
Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
Atherosclerosis
Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells.
Atherosclerosis
Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice.
Atherosclerosis
Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis.
Atherosclerosis
Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Atherosclerosis
Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.
Atherosclerosis
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Atherosclerosis
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Atherosclerosis
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Atherosclerosis
Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors.
Atherosclerosis
Emodin inhibits tumor necrosis factor-?-induced migration and inflammatory responses in rat aortic smooth muscle cells.
Atherosclerosis
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Atherosclerosis
Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-?Da Laminin Receptor and the TLR4/MAPK/NF-?B Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Atherosclerosis
Evaluation of Cardiovascular Changes in Children with BAVs.
Atherosclerosis
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Atherosclerosis
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Atherosclerosis
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Atherosclerosis
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Atherosclerosis
Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Atherosclerosis
Ginkgetin ameliorates experimental atherosclerosis in rats.
Atherosclerosis
Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques.
Atherosclerosis
Group IVA phospholipase A2-associated production of MMP-9 in macrophages and formation of atherosclerotic lesions.
Atherosclerosis
Haplotype Analysis of the Stromelysin-1 (MMP3) and Gelatinase B (MMP9) Genes in Relation to Coronary Heart Disease.
Atherosclerosis
Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease.
Atherosclerosis
High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.
Atherosclerosis
Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration.
Atherosclerosis
Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells.
Atherosclerosis
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects.
Atherosclerosis
In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin.
Atherosclerosis
Increased MMP-2 in healthy postmenopausal women.
Atherosclerosis
Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
Atherosclerosis
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Atherosclerosis
Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis.
Atherosclerosis
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.
Atherosclerosis
Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.
Atherosclerosis
Inhibitory effect of Zanthoxylum schinifolium on vascular smooth muscle proliferation.
Atherosclerosis
Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.
Atherosclerosis
Interaction Between MMP-9 Gene Polymorphisms and Smoking in Relation to Myocardial Infarction in a Uighur Population.
Atherosclerosis
Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
Atherosclerosis
Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders.
Atherosclerosis
Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.
Atherosclerosis
Investigation of RNA interference suppression of matrix metalloproteinase-9 in mouse model of atherosclerosis.
Atherosclerosis
Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.
Atherosclerosis
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
Atherosclerosis
Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis.
Atherosclerosis
Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.
Atherosclerosis
Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3?.
Atherosclerosis
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Atherosclerosis
Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.
Atherosclerosis
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Atherosclerosis
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.
Atherosclerosis
Matrix metalloprotease-9 polymorphism and its association with Atherosclerosis - A case-control study in Pakistani population.
Atherosclerosis
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Atherosclerosis
Matrix metalloproteinase-9 and autoimmune diseases.
Atherosclerosis
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Atherosclerosis
Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.
Atherosclerosis
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Atherosclerosis
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Atherosclerosis
Metabolic endotoxaemia in childhood obesity.
Atherosclerosis
Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure.
Atherosclerosis
microRNA-204-5p Participates in Atherosclerosis Via Targeting MMP-9.
Atherosclerosis
MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse.
Atherosclerosis
MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
HOME
login
history
all enzymes
BRENDA home
History
3.4.24.35 gelatinase B
more
top
